Literature DB >> 8213549

Frequency of presumed reentry with an excitable gap in sustained ventricular tachycardia unassociated with coronary artery disease.

Y Aizawa1, N Naitoh, H Kitazawa, Y Kusano, H Uchiyama, T Washizuka, A Shibata.   

Abstract

In sustained ventricular tachycardia (VT) unrelated to coronary artery disease, the incidence of reentry with an excitable gap was examined, and rapid pacing was performed to entrain VT in 48 episodes in 42 consecutive patients. Coronary artery disease was excluded by coronary arteriography. The underlying heart diseases were postoperative congenital heart diseases (n = 5), dilated (n = 7) or hypertrophic (n = 4) cardiomyopathy, arrhythmogenic right ventricular dysplasia (n = 6) and miscellaneous heart diseases (n = 5), as well as no demonstrable heart disease (n = 15) in which 8 patients had verapamil-responsive VT. Except for 1 patient with hypertrophic cardiomyopathy, 48 morphologically distinct monomorphic sustained VTs were induced. Twenty-five VTs showed right bundle branch block morphology and 23 left bundle branch block morphology, and VT was entrained in 84 and 96%, respectively. The overall incidence of the entrainment was 89.6% (43 of 48 monomorphic VTs), and the frequency of the ability to entrain VT ranged between 33.3 and 100% in the subgroups. The lowest frequency was found in hypertrophic cardiomyopathy. In conclusion, most inducible monomorphic sustained VT unassociated with coronary artery disease was presumed to be reentry with an excitable gap.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8213549     DOI: 10.1016/0002-9149(93)91107-s

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

Authors:  Mohammed Qintar; Abdulrahman Morad; Hazem Alhawasli; Khaled Shorbaji; Belal Firwana; Adib Essali; Waleed Kadro
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 2.  The anatomic basis for ventricular arrhythmia in the normal heart: what the student of anatomy needs to know.

Authors:  Jo Jo Hai; Nirusha Lachman; Faisal F Syed; Christopher V Desimone; Samuel J Asirvatham
Journal:  Clin Anat       Date:  2014-01-20       Impact factor: 2.414

3.  Ventricular tachycardia initiated by high energy cardioversion in a patient with an implantable cardioverter defibrillator.

Authors:  M Chinushi; Y Aizawa; K Higuchi
Journal:  Heart       Date:  1997-04       Impact factor: 5.994

4.  Radiofrequency catheter ablation for idiopathic right ventricular tachycardia with special reference to morphological variation and long-term outcome.

Authors:  M Chinushi; Y Aizawa; K Takahashi; H Kitazawa; A Shibata
Journal:  Heart       Date:  1997-09       Impact factor: 5.994

5.  Discrepant effects of mexiletine on cycle length of ventricular tachycardia and on the effective refractory period in the area of slow conduction.

Authors:  Y Aizawa; M Chinushi; H Kitazawa; T Washizuka; A Abe; A Shibata; I Kodama
Journal:  Heart       Date:  1996-03       Impact factor: 5.994

6.  Anti-tachycardia pacing for non-fast and fast ventricular tachycardias in individual Japanese patients: From Nippon-storm study.

Authors:  Masaomi Chinushi; Osamu Saitoh; Hiroshi Furushima; Yoshifusa Aizawa; Takashi Noda; Takashi Nitta; Tohru Ohe; Takashi Kurita
Journal:  J Arrhythm       Date:  2021-06-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.